Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
A.23NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.596.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.596.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.596.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.473NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.473NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.473NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.595.2NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-16197.2US
B.1.595.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.595.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-16933China
BA.2.76.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BA.2.76.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.2.76.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.2.38.4NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BA.2.38.4NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.2.38.4NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.2.38.3NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BA.2.38.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.2.38.3NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BM.4NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BM.4NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BM.4NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
HH.6NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
HH.6NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
HH.6NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
KN.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
KN.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
KN.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
AY.43.1 (Delta)NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
AY.43.1 (Delta)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AY.43.1 (Delta)NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.332NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.332NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.332NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
JB.2.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
JB.2.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JB.2.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.2.86.7NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BA.2.86.7NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.2.86.7NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.12NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.12NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.12NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
JW.1.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
JW.1.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JW.1.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XBB.2.3.18NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XBB.2.3.18NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.2.3.18NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XBC.1.6.5NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used